These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 8889053

  • 1. A poliovirus-susceptible transgenic mouse model as a possible replacement for the monkey neurovirulence test of oral poliovirus vaccine.
    Dragunsky E, Taffs R, Chernokhvostova Y, Nomura T, Hioki K, Gardner D, Norwood L, Levenbook I.
    Biologicals; 1996 Jun; 24(2):77-86. PubMed ID: 8889053
    [Abstract] [Full Text] [Related]

  • 2. Transgenic PVR Tg-1 mice for testing of poliovirus type 3 neurovirulence: comparison with monkey test.
    Dragunsky E, Gardner D, Taffs R, Levenbook I.
    Biologicals; 1993 Sep; 21(3):233-7. PubMed ID: 8117436
    [Abstract] [Full Text] [Related]

  • 3. Development of a neurovirulent testing system for oral poliovirus vaccine with transgenic mice.
    Levenbook I, Nomura T.
    Lab Anim Sci; 1997 Apr; 47(2):118-20. PubMed ID: 9150487
    [Abstract] [Full Text] [Related]

  • 4. Transgenic mice as an alternative to monkeys for neurovirulence testing of live oral poliovirus vaccine: validation by a WHO collaborative study.
    Dragunsky E, Nomura T, Karpinski K, Furesz J, Wood DJ, Pervikov Y, Abe S, Kurata T, Vanloocke O, Karganova G, Taffs R, Heath A, Ivshina A, Levenbook I.
    Bull World Health Organ; 2003 Apr; 81(4):251-60. PubMed ID: 12764491
    [Abstract] [Full Text] [Related]

  • 5. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype.
    Rezapkin GV, Fan L, Asher DM, Fibi MR, Dragunsky EM, Chumakov KM.
    Virology; 1999 May 25; 258(1):152-60. PubMed ID: 10329577
    [Abstract] [Full Text] [Related]

  • 6. Some aspects of the monkey neurovirulence test used for the assessment of oral poliovirus vaccines.
    Furesz J, Contreras G.
    Dev Biol Stand; 1993 May 25; 78():61-70. PubMed ID: 8388832
    [Abstract] [Full Text] [Related]

  • 7. [The observation on infection of trasgenic mice (PVR Tg21) with polioviruses type 3].
    Guo R, Chen S, Luo Q, Wang Q.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Feb 25; 20(1):70-5. PubMed ID: 11367738
    [Abstract] [Full Text] [Related]

  • 8. Oral poliovirus vaccine type 3 from a patient with transverse myelitis is neurovirulent in a transgenic mouse model.
    Thorley B, Kelly H, Nishimura Y, Yoon YK, Brussen KA, Roberts J, Shimizu H.
    J Clin Virol; 2009 Apr 25; 44(4):268-71. PubMed ID: 19269246
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice.
    Abe S, Ota Y, Koike S, Kurata T, Horie H, Nomura T, Hashizume S, Nomoto A.
    Virology; 1995 Feb 01; 206(2):1075-83. PubMed ID: 7856082
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Poliovirus attenuation and pathogenesis in a transgenic mouse model for poliomyelitis.
    Racaniello VR, Ren R, Bouchard M.
    Dev Biol Stand; 1993 Feb 01; 78():109-16. PubMed ID: 8388820
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Poliovirus-sensitive transgenic mice as a new animal model.
    Koike S, Horie H, Sato Y, Ise I, Taya C, Nomura T, Yoshioka I, Yonekawa H, Nomoto A.
    Dev Biol Stand; 1993 Feb 01; 78():101-7. PubMed ID: 8388819
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Development of a transgenic mouse neurovirulence test for oral poliovirus vaccine: international collaborative study 1993-1999.
    Levenbook I, Dragunsky E, Pervikovc Y.
    Vaccine; 2000 Sep 15; 19(2-3):163-6. PubMed ID: 10930668
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy.
    Dragunsky EM, Ivanov AP, Wells VR, Ivshina AV, Rezapkin GV, Abe S, Potapova SG, Enterline JC, Hashizume S, Chumakov KM.
    J Infect Dis; 2004 Oct 15; 190(8):1404-12. PubMed ID: 15378432
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.